AKI episodes reviewed
60
Sample data
AKI recognised and documented
86.7%
Target ≥ 90%
Review within local target
58.3%
Timely clinical review for AKI stage
Medication review completed
76.7%
Nephrotoxin and renal dosing review
Aim
To assess whether adults with suspected or confirmed AKI receive timely recognition, clinical review, investigation, management, escalation and follow-up planning in line with local policy and NICE guidance.
Standards
NICE NG148 · NICE QS76 — AKI recognition, review, medication review, fluid assessment and follow-up (local target ≥ 90%)
Sample
Target sample 60 consecutive adult admissions (≥ 16y) with suspected or confirmed AKI across participating wards, units and pathways. Pseudonymised only — no direct patient identifiers. Discharge follow-up documented in 65% of demo cases.
Tool workflow
Step 1
Project setup
Confirm scope, wards, leads, local AKI policy references and audit cycle.
Step 2
Team
Add supervisors, renal, pharmacy, nursing and governance leads.
Step 3
Inclusion / exclusion
Review who is in scope and the 26 audit criteria.
Step 4
Collect data
Structured form for each AKI episode.
Step 5
Dashboard
Recognition, review within target, ward comparison, run chart and gaps.
Step 6
Findings
Interpret results, good practice and gaps.
Step 7
Improvement
Plan actions, PDSA cycles and re-audit.
Step 8
Resources
NICE NG148, QS76 and local policy references.
Step 9
Export centre
Editable Word, PowerPoint, poster, Excel and ARCP outputs.
Add a case
Open the structured data collection form.
Plan improvement
PDSA cycles, actions and re-audit plan.
Generate outputs
Word, PowerPoint, A0 poster, Excel and ARCP evidence.
Clinical safety note
This tool supports local audit, quality improvement and governance review. It does not replace clinical judgement, local AKI policy, renal advice, critical care advice, medicines safety advice, fluid prescribing policy, antimicrobial guidance, contrast policy, escalation pathways or emergency treatment. Urgent clinical deterioration, severe AKI, hyperkalaemia, pulmonary oedema, severe acidosis, obstruction, sepsis or need for renal replacement therapy must be managed according to local escalation pathways. Do not enter patient names, NHS numbers, hospital numbers, full dates of birth, addresses or other direct identifiers.